COHN vs MLCI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
COHN presents a classic deep-value opportunity with a Piotroski F-Score of 4/9 indicating stable financial health and a current price ($21.88) trading significantly below both its Graham Number ($53.43) and Intrinsic Value ($30.45). The company exhibits explosive revenue growth (493.40% YoY) and an exceptional ROE of 41.51%, though these are offset by high leverage (Debt/Equity 4.41). While technical trends and insider sentiment are currently bearish, the fundamental valuation gap and profitability metrics suggest significant upside potential.
MLCI exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. While the company trades at a significant discount to book value (P/B 0.57), this is offset by catastrophic profitability margins (-137.62% profit margin) and a negative ROE of -62.40%. Despite a high current ratio suggesting short-term liquidity, the technical trend is completely bearish (0/100) and quarterly revenue has plummeted by 44.54%. The dividend appears unsustainable given the lack of earnings.
Compare Another Pair
Related Comparisons
COHN vs MLCI: Head-to-Head Comparison
This page compares Cohen & Company Inc. (COHN) and Mount Logan Capital Inc. (MLCI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.